Frontlight ResearchEarly access
Trial site
Park Nicollet Frauenshuh Cancer Center
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Ovarian cancer3 trials
- Colorectal cancer2 trials
- Head and neck cancer2 trials
- Bladder cancer1 trial
- Endometrial cancer1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Seagen, a wholly owned subsidiary of Pfizer4 trials
- Pfizer2 trials
- CanariaBio Inc.1 trial
- National Cancer Institute (NCI)1 trial
Running trials
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026